Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-110,750
Closed -$439K 306
2022
Q4
$439K Sell
110,750
-21,819
-16% -$124K 0.08% 178
2022
Q3
$811K Buy
132,569
+5,518
+4% +$42K 0.14% 139
2022
Q2
$624K Sell
127,051
-11,353
-8% -$99.2K 0.1% 153
2022
Q1
$1.75M Buy
138,404
+41,316
+43% +$455K 0.21% 134
2021
Q4
$1.19M Buy
97,088
+77,088
+385% +$1.36M 0.13% 159
2021
Q3
$366K Buy
+20,000
New +$221K 0.04% 262
2021
Q2
Sell
-12,500
Closed -$306K 335
2021
Q1
$306K Buy
+12,500
New +$140K 0.03% 287

Other funds holding AMTX

L & S Advisors's AMTX Position: Q1 2023 in Review

L & S Advisors sold out of Aemetis (AMTX) in Q1 2023, closing a stake of 110,750 shares — an estimated $439K sold.

L & S Advisors first reported a position in AMTX in Q1 2021 and held it in 7 quarters. The position peaked at $1.75M in Q1 2022. 77 funds tracked by Wall St. Rank hold AMTX as of Q1 2023.

  • L & S Advisors reported no remaining Aemetis position as of Q1 2023 after selling out during the quarter.
  • L & S Advisors sold 110,750 Aemetis shares in Q1 2023, an estimated $439K.
  • L & S Advisors first reported a position in Aemetis in Q1 2021 and held it in 7 quarters.
  • L & S Advisors's Aemetis position peaked at $1.75M in Q1 2022.
  • 77 funds tracked by Wall St. Rank held Aemetis as of Q1 2023.

Based on L & S Advisors's 13F filing for Q1 2023, filed 10 May 2023.